DIA

DIA appoints Lyngvig as new European director

Tuesday, December 18, 2012 01:55 PM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, has appointed Jytte Lyngvig as director for DIA Europe.

More... »

DIA begins transition to new executive leadership

Monday, December 10, 2012 09:12 AM

DIA, a neutral, global, nonprofit association that provides knowledge resources across the full spectrum of medical product development, announced that Paul Pomerantz, worldwide executive director of DIA, will be leaving effective March 3, 2013, to assume the position of CEO for the American Society of Anesthesiologists.

More... »

Saladax Biomedical appoints Myslinski as CCO

Friday, November 16, 2012 12:18 PM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company that develops diagnostic assays for the practical delivery of personalized medicine, has appointed Mark D. Myslinski as senior vice president and chief commercial officer.

More... »

CRA, Radiant Research form largest, most therapeutically diverse SMO in U.S.

Monday, November 5, 2012 01:15 PM

CRA Holdings has acquired Radiant Research, a comprehensive research company based in Cincinnati. Clinical Research Advantage (CRA), a provider of research services also owned by CRA Holdings, will be combined with Radiant Research, creating an organization with 57 sites with more than 550 research professionals and an aggressive plan for growth.

More... »

CRA Holdings acquires Radiant Research

Friday, October 26, 2012 03:16 PM

Kinderhook Industries has announced the acquisition of Radiant Research by CRA Holdings, one of its portfolio companies. The deal represents the eighth healthcare services transaction completed by Kinderhook. Financial terms of the transaction were not disclosed.

More... »

Allegro Diagnostics reveals positive results of BronchoGen genomic test for lung cancer

Wednesday, October 24, 2012 11:43 AM

Allegro Diagnostics, a molecular diagnostics company based in Maynard, Mass., released positive results from the AEGIS I (Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer) clinical trial, which demonstrate the diagnostic accuracy of the BronchoGe genomic test in combination with bronchoscopy.

More... »

Resverlogix initiates phase II trial of RVX-208 in pre-diabetes

Friday, October 19, 2012 03:20 PM

Resverlogix, a Canadian clinical stage cardiovascular company, has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.

More... »

SpringFire Laboratory Network adds ReproSource to affiliate laboratories

Friday, October 19, 2012 10:32 AM

SpringFire Laboratory Network, a network of independent, esoteric, high complexity laboratories, has added ReproSource Fertility Diagnostics, a Boston-based clinical laboratory and research organization that provides solutions for fertility testing and education, to its network of affiliate laboratories, which provides specialized testing services to clinical trial sponsors and CROs.

More... »

MMG, Remedy Health to bolster clinical trial enrollment

Wednesday, October 17, 2012 03:46 PM

MMG, a global health communications company specializing in clinical trial patient recruitment and retention, has formed an exclusive partnership with Remedy Health Media, a health information and technology company, to deliver unique access to a larger pool of qualified potential clinical trial participants.

More... »

Investigational drugs chosen for major Alzheimer's prevention trial

Thursday, October 11, 2012 07:00 AM

Scientists have selected the first investigational drugs for a worldwide Alzheimer's disease prevention trial. The pioneering study, expected to start by early 2013, initially will test three promising drugs—gantenerumab, solanezumab and an unnamed BACE inhibitor—each designed to target Alzheimer's in different ways.

More... »